UNIVERSITY OF PITTSBURGH MEDICAL CENTER

Analysis

The UNIVERSITY OF PITTSBURGH MEDICAL CENTER has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This matter is located within a distinct art unit, reflecting a focused technical scope for the institution's current patent activity. The prosecution is handled by 1 distinct examiner, which centralizes the communication and negotiation process between the applicant and the patent office. This focused approach is typical for portfolios with limited active filings, where the goal is to resolve the outstanding matter efficiently through a single point of contact.

The busiest examiner, COPPINS, JANET L, is responsible for the pending office action. Since this is the only pending action in the portfolio, the examiner's individual review will determine the immediate path forward for the medical center's intellectual property. This single-examiner environment simplifies the prosecution strategy by removing the need to reconcile different examiner viewpoints or art unit practices. Practitioners should prioritize a clear and direct dialogue with COPPINS, JANET L to address any technical rejections or prior art concerns raised in the 1 distinct art unit.

The presence of a distinct art unit in the Biotechnology & Pharmaceuticals field indicates that the technology is being evaluated by a specific group of experts. Because there is only 1 pending office action, the practitioner can focus exclusively on the concerns of the assigned examiner. This concentrated effort is beneficial for ensuring a thorough and effective response to the patent office's requirements. Success in this matter will secure the institution's position in the life sciences sector and provide a foundation for future research commercialization.